Use of tyrosine kinase inhibitors for the treatment of chronic rhinosinusitis

Details for Australian Patent Application No. 2006210175 (hide)

Owner Boehringer Ingelheim Pharma GmbH & Co. KG Boehringer Ingelheim International GmbH

Inventors Pohl, Gerald; Jung, Birgit; Disse, Bernd

Agent Davies Collison Cave

Pub. Number AU-A-2006210175

PCT Pub. Number WO2006/082129

Priority 102005036216.8 02.08.05 DE; 102005005505.2 04.02.05 DE

Filing date 16 January 2006

Wipo publication date 10 August 2006

International Classifications

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

13 September 2007 PCT application entered the National Phase

  PCT publication WO2006/082129 Priority application(s): WO2006/082129

24 April 2008 Alteration of Name

  The name of the applicant has been altered to Boehringer Ingelheim International GmbH

11 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006210223-Method and device for controlling network elements in a decentralized network

2006210167-Tap assembly with overfill protection and level gauge